#1 Clinical Trials Search in Europe

Colecalciferol

This article explores the use of colecalciferol, also known as vitamin D3, in various clinical trials. Colecalciferol is being studied as a potential treatment or supplement for multiple conditions, including multiple sclerosis, inflammatory bowel diseases, vitamin D deficiency, and more. The trials aim to evaluate the safety, efficacy, and optimal dosing of colecalciferol supplementation in different patient populations.

Table of Contents

What is Colecalciferol?

Colecalciferol, also known as vitamin D3, is a form of vitamin D that is essential for human health[1]. It is naturally produced in our skin when exposed to sunlight and can also be obtained through diet or supplements. Colecalciferol is crucial for maintaining strong bones, regulating calcium and phosphate levels in the body, and supporting overall health[2].

Medical Uses

Colecalciferol is used to treat and prevent various health conditions related to vitamin D deficiency. Some of the main medical uses include:

  • Multiple Sclerosis (MS): Colecalciferol is being studied as an add-on treatment to interferon-beta-1b for patients with MS. Researchers believe it may help suppress clinical and MRI activity of the disease[1].
  • Inflammatory Bowel Diseases (IBD): Vitamin D supplementation is being investigated to determine the optimal dose for patients with IBD during winter months[2].
  • Chronic Kidney Disease: Colecalciferol is used to treat secondary hyperparathyroidism in patients with chronic kidney disease[3].
  • HIV Infection: Vitamin D supplementation is being studied to improve bone density, immune function, and adipocyte (fat cell) function in HIV-positive patients[4].
  • Uterine Fibroids: Research is ongoing to determine if vitamin D supplementation can inhibit the growth of uterine fibroids in women of reproductive age[5].
  • Epilepsy: Studies are being conducted to determine the appropriate maintenance dose of vitamin D for children with epilepsy to prevent vitamin D deficiency[7].

Dosage and Administration

The dosage of colecalciferol can vary depending on the condition being treated and the individual’s vitamin D status. Some common dosages observed in clinical trials include:

  • 20,000 IU (0.5 mg) once weekly for MS patients[1]
  • 1,600 IU daily for patients with vitamin D deficiency and uterine fibroids[5]
  • 800 IU daily for patients with vitamin D insufficiency and uterine fibroids[5]
  • 400 IU or 1000 IU daily for children with epilepsy[7]

It’s important to note that these dosages are from clinical trials and may not be appropriate for everyone. Always consult with your healthcare provider to determine the right dosage for your specific needs.

Benefits

Colecalciferol supplementation may offer several potential benefits, including:

  • Improved bone health and reduced risk of osteoporosis[4]
  • Enhanced immune function[3][4]
  • Potential reduction in MS disease activity[1]
  • Possible inhibition of uterine fibroid growth[5]
  • Improved vitamin D status in patients with various health conditions[2][7]

Side Effects and Safety

While colecalciferol is generally considered safe when taken as directed, some potential side effects and safety concerns include:

  • Hypercalcemia (high calcium levels in the blood)[5]
  • Abnormal liver function[5]
  • Urinary calculus (kidney stones)[5]
  • Abnormal renal function[5]

It’s important to monitor vitamin D levels, calcium levels, and other relevant markers when taking colecalciferol supplements, especially at higher doses or for extended periods.

Ongoing Research

Several clinical trials are currently investigating the effects of colecalciferol supplementation in various conditions:

  • Its potential as an add-on treatment for multiple sclerosis[1]
  • Optimal dosing for patients with inflammatory bowel diseases[2]
  • Effects on bone metabolism and immune system in dialysis patients[3]
  • Impact on HIV-positive patients’ bone density and immune function[4]
  • Potential to inhibit uterine fibroid growth[5]
  • Pharmacokinetics in healthy adults and those with intestinal malabsorption[8]
  • Effects of supplementation during pregnancy and lactation[9][10]

These ongoing studies aim to provide more insights into the potential benefits and optimal use of colecalciferol in various health conditions.

Aspect Details
Main Conditions Studied Multiple Sclerosis, Inflammatory Bowel Disease, Vitamin D Deficiency, HIV, Chronic Kidney Disease, Uterine Fibroids
Dosage Range Varies by study: 400 IU/day to 20,000 IU/week
Administration Method Oral capsules or drops
Primary Outcomes Measured Vitamin D levels, disease-specific markers, safety and tolerability
Secondary Outcomes Bone mineral density, immune function, calcium levels, disease progression
Study Designs Randomized, double-blind, placebo-controlled trials
Patient Populations Adults and children with specific conditions or healthy volunteers
Duration of Studies Ranges from several weeks to two years

FAQ

  • What is colecalciferol? Colecalciferol is another name for vitamin D3, a form of vitamin D that is naturally produced in the skin when exposed to sunlight. It is also available as a dietary supplement and is being studied in various clinical trials for its potential health benefits.
  • What conditions are being studied with colecalciferol supplementation? Clinical trials are investigating colecalciferol supplementation for multiple conditions, including multiple sclerosis, inflammatory bowel diseases, vitamin D deficiency, HIV infection, chronic kidney disease, and uterine fibroids.
  • How is colecalciferol administered in these trials? In most trials, colecalciferol is administered orally in the form of capsules or drops. The dosage and frequency vary depending on the study, ranging from daily doses to weekly doses.
  • What are some potential benefits of colecalciferol supplementation? Potential benefits being studied include improved bone health, enhanced immune function, better management of multiple sclerosis symptoms, and prevention of vitamin D deficiency in various patient populations.
  • Are there any safety concerns with colecalciferol supplementation? While colecalciferol is generally considered safe, some trials are monitoring for potential side effects such as hypercalcemia (high blood calcium levels) and changes in liver or kidney function. The safety profile is being evaluated in different patient groups and at various dosages.

Ongoing Clinical Trials on Colecalciferol

  • High-Dose Colecalciferol for 28-Day Mortality in Critically Ill Adults with Severe Vitamin D Deficiency

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Germany

  • Study on Vitamin D3 (Colecalciferol) Supplementation in Young Adults and Seniors to Compare Effects and Develop Age-Specific Models

    Recruiting

    3 1 1 1
    Investigated drugs:
    Czechia

  • Study on the Effects of Cholecalciferol and Glycerol on Inflammation in Obese Elderly Patients with Vitamin D Deficiency

    Recruiting

    3 1 1
    Investigated drugs:
    Italy

  • Study on Vitamin D and Oral Iron for Patients with Chronic Heart Failure and Iron Deficiency

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study on High-Dose Vitamin D3 and Glycerol for Improving Wound Healing After Wisdom Tooth Removal in Patients with Vitamin D Insufficiency

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria

  • Study on the Early Use of Levosimendan Compared to Placebo for Patients with Cardiogenic Shock

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Comparison of Two Vitamin D3 Doses (500,000 IU vs 750,000 IU) in Critically Ill Patients with Vitamin D Deficiency Receiving Continuous Renal Replacement Therapy

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland

  • Study on Vitamin D (Colecalciferol) to Increase Free Testosterone in Men with Type 2 Diabetes and Low Testosterone Levels

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium

  • Study on Improving Bone Health in Children with Cystic Fibrosis Using Cholecalciferol

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia

  • Study on the Effects of Levosimendan for Patients with Cardiogenic Shock Being Weaned from ECMO

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Austria

Glossary

  • Colecalciferol: A form of vitamin D, also known as vitamin D3, that is produced in the skin when exposed to sunlight and can be taken as a dietary supplement.
  • 25-hydroxyvitamin D: The main circulating form of vitamin D in the blood, used to measure vitamin D status in the body.
  • Multiple Sclerosis (MS): A chronic disease affecting the central nervous system, where the immune system attacks the protective covering of nerves.
  • Inflammatory Bowel Disease (IBD): A group of disorders that cause chronic inflammation of the digestive tract, including conditions like Crohn's disease and ulcerative colitis.
  • Hyperparathyroidism: A condition where the parathyroid glands produce too much parathyroid hormone, affecting calcium levels in the body.
  • Osteopenia: A condition where bone density is lower than normal, but not low enough to be classified as osteoporosis.
  • Osteoporosis: A bone disease characterized by decreased bone mass and density, increasing the risk of fractures.
  • Uterine Fibroids: Noncancerous growths in the uterus that can develop during a woman's childbearing years.
  • Hypercalcemia: A condition characterized by higher than normal levels of calcium in the blood.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.

References

  1. https://clinicaltrials.gov/study/NCT01432704
  2. https://clinicaltrials.gov/study/NCT02958501
  3. https://clinicaltrials.gov/study/NCT00397475
  4. https://clinicaltrials.gov/study/NCT00306410
  5. https://clinicaltrials.gov/study/NCT03584529
  6. https://clinicaltrials.gov/study/NCT01339676
  7. https://clinicaltrials.gov/study/NCT03536845
  8. https://clinicaltrials.gov/study/NCT03401541
  9. https://clinicaltrials.gov/study/NCT02297568
  10. https://clinicaltrials.gov/study/NCT03743922